1. Home
  2. INDP
  3. INDP News

Latest Indaptus Therapeutics Inc. (INDP) News on April 24, 2025

Indaptus Therapeutics Chief Medical Officer Roger Waltzman, M.D., M.B.A. to Moderate Panel at CMO360 Summit
INDP

GlobeNewswire

a month ago

Indaptus Therapeutics Chief Medical Officer Roger Waltzman, M.D., M.B.A. to Moderate Panel at CMO360 Summit

Indaptus Therapeutics Reports New Data Demonstrating Successful Broad Immune System Activation in Weekly Dosing Trial of Decoy20
INDP

GlobeNewswire

a month ago

Indaptus Therapeutics Reports New Data Demonstrating Successful Broad Immune System Activation in Weekly Dosing Trial of Decoy20

Indaptus Therapeutics Initiates Phase 1 Combination Study of Decoy20 with PD-1 Checkpoint Inhibitor Tislelizumab
INDP

GlobeNewswire

a month ago

Indaptus Therapeutics Initiates Phase 1 Combination Study of Decoy20 with PD-1 Checkpoint Inhibitor Tislelizumab

Indaptus Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Corporate Update
INDP

GlobeNewswire

a month ago

Indaptus Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Corporate Update

Registration Is Now Open For Tribe Public’s Webinar Event “Keys To The Kingdom: Unlocking The Power Of Your Immune System” Featuring Indaptus Therapeutics’ CEO On Monday, March 17, 2025
INDP

GlobeNewswire

a month ago

Registration Is Now Open For Tribe Public’s Webinar Event “Keys To The Kingdom: Unlocking The Power Of Your Immune System” Featuring Indaptus Therapeutics’ CEO On Monday, March 17, 2025

Indaptus Therapeutics Expands Patent Portfolio in China, Japan, and Israel, Strengthening its Intellectual Property for Infectious Disease and Cancer Treatments
INDP

GlobeNewswire

2 months ago

Indaptus Therapeutics Expands Patent Portfolio in China, Japan, and Israel, Strengthening its Intellectual Property for Infectious Disease and Cancer Treatments

Indaptus Therapeutics’ Chief Scientific Officer Dr. Michael Newman to Present at the 10th Annual Innate Killer Summit
INDP

GlobeNewswire

2 months ago

Indaptus Therapeutics’ Chief Scientific Officer Dr. Michael Newman to Present at the 10th Annual Innate Killer Summit

Indaptus Therapeutics Receives Approval from Health Canada to Expand Clinical Trial of Decoy20
INDP

GlobeNewswire

3 months ago

Indaptus Therapeutics Receives Approval from Health Canada to Expand Clinical Trial of Decoy20

Indaptus Therapeutics, Inc. Announces $2.25 Million Private Placement Priced At-The-Market Under Nasdaq Rules
INDP

GlobeNewswire

3 months ago

Indaptus Therapeutics, Inc. Announces $2.25 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Indaptus Therapeutics Provides Year-End Review and Outlook for 2025
INDP

GlobeNewswire

4 months ago

Indaptus Therapeutics Provides Year-End Review and Outlook for 2025

Indaptus Therapeutics, Inc. Announces $2.135 Million Registered Direct Offering and Concurrent Private Placement
INDP

GlobeNewswire

5 months ago

Indaptus Therapeutics, Inc. Announces $2.135 Million Registered Direct Offering and Concurrent Private Placement

Indaptus Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
INDP

GlobeNewswire

5 months ago

Indaptus Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Indaptus Therapeutics’ Pioneering Research on Novel Immunotherapy Approach Published in Peer-Reviewed Frontiers in Immunology
INDP

GlobeNewswire

5 months ago

Indaptus Therapeutics’ Pioneering Research on Novel Immunotherapy Approach Published in Peer-Reviewed Frontiers in Immunology

Indaptus Therapeutics Presents Encouraging Interim Safety Data from Phase 1 Clinical Trial of Decoy20 at the Society for Immunotherapy of Cancer (SITC) 2024 Annual Meeting
INDP

GlobeNewswire

6 months ago

Indaptus Therapeutics Presents Encouraging Interim Safety Data from Phase 1 Clinical Trial of Decoy20 at the Society for Immunotherapy of Cancer (SITC) 2024 Annual Meeting

Indaptus Therapeutics to Present at Two Upcoming Investor Conferences
INDP

GlobeNewswire

6 months ago

Indaptus Therapeutics to Present at Two Upcoming Investor Conferences

Indaptus Therapeutics Announces Clinical Supply Agreement with BeiGene to Evaluate Novel Cancer Treatment Combinations
INDP

GlobeNewswire

6 months ago

Indaptus Therapeutics Announces Clinical Supply Agreement with BeiGene to Evaluate Novel Cancer Treatment Combinations

Indaptus Therapeutics Initiates Unrestricted Enrollment of Patients on Decoy20 Weekly Dosing Based on Encouraging Safety Data
INDP

GlobeNewswire

6 months ago

Indaptus Therapeutics Initiates Unrestricted Enrollment of Patients on Decoy20 Weekly Dosing Based on Encouraging Safety Data

Indaptus Therapeutics Founder and Chief Scientific Officer to Speak on Lumanity Webinar about the Future of Innate Immunity in Cancer Immunotherapy
INDP

GlobeNewswire

6 months ago

Indaptus Therapeutics Founder and Chief Scientific Officer to Speak on Lumanity Webinar about the Future of Innate Immunity in Cancer Immunotherapy

Indaptus Therapeutics to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
INDP

GlobeNewswire

7 months ago

Indaptus Therapeutics to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit

Indaptus Therapeutics Reports Encouraging New Safety Data for Decoy20 Clinical Program; Company Expands Enrollment of Patients on Weekly Dosing at Two Different Doses
INDP

GlobeNewswire

8 months ago

Indaptus Therapeutics Reports Encouraging New Safety Data for Decoy20 Clinical Program; Company Expands Enrollment of Patients on Weekly Dosing at Two Different Doses

Indaptus Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
INDP

GlobeNewswire

8 months ago

Indaptus Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Indaptus Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
INDP

GlobeNewswire

8 months ago

Indaptus Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Insider Buyers Lose US$41k As Indaptus Therapeutics Sheds US$1.2m
INDP

Simply Wall St.

8 months ago

Insider Buyers Lose US$41k As Indaptus Therapeutics Sheds US$1.2m

Indaptus Therapeutics, Inc. Announces $3.0 Million Registered Direct Offering and Concurrent Private Placement
INDP

GlobeNewswire

9 months ago

Indaptus Therapeutics, Inc. Announces $3.0 Million Registered Direct Offering and Concurrent Private Placement

Indaptus Therapeutics to Present Positive Data on Lead Product Candidate, Decoy20, at STING & TLR-Targeted Therapies Summit
INDP

GlobeNewswire

10 months ago

Indaptus Therapeutics to Present Positive Data on Lead Product Candidate, Decoy20, at STING & TLR-Targeted Therapies Summit

Lotto 6/49 - $64 million up for grabs in the next draw!
INDP

CNW Group

a year ago

Lotto 6/49 - $64 million up for grabs in the next draw!

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture
INDP

Simply Wall St.

a year ago

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Seoul says it will resume loudspeaker propaganda against North
INDP

AFP

a year ago

Seoul says it will resume loudspeaker propaganda against North

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend
INDP

Simply Wall St.

a year ago

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m
INDP

Simply Wall St.

a year ago

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week
INDP

Barrons.com

a year ago

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend
INDP

Simply Wall St.

a year ago

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued
INDP

Simply Wall St.

a year ago

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Trip.com Reveals 2024 Trip.Best Global and Asia 100 Rankings
INDP

CNW Group

a year ago

Trip.com Reveals 2024 Trip.Best Global and Asia 100 Rankings

The Company Behind Mounjaro and Zepbound Is Sponsoring Caitlin Clark. Should You Buy the Stock?
INDP

Motley Fool

a year ago

The Company Behind Mounjaro and Zepbound Is Sponsoring Caitlin Clark. Should You Buy the Stock?

3 Capital Markets Stocks to Buy Hand Over Fist in June
INDP

Motley Fool

a year ago

3 Capital Markets Stocks to Buy Hand Over Fist in June

3 Types of Homes To Buy During Summer 2024 To Get Rich
INDP

GOBankingRates

a year ago

3 Types of Homes To Buy During Summer 2024 To Get Rich

4 Ways the Upper Class Handles Inflation That the Middle Class Could Learn From
INDP

GOBankingRates

a year ago

4 Ways the Upper Class Handles Inflation That the Middle Class Could Learn From

Gaming laptops are being left behind
INDP

Digital Trends

a year ago

Gaming laptops are being left behind

What a Comfortable Retirement Will Cost You in 61 of the Largest US Cities
INDP

GOBankingRates

a year ago

What a Comfortable Retirement Will Cost You in 61 of the Largest US Cities

I’m a Financial Advisor: Here Are the 6 Worst Secrets You Can Keep from Me
INDP

GOBankingRates

a year ago

I’m a Financial Advisor: Here Are the 6 Worst Secrets You Can Keep from Me

Getting smarter: FIA Launches 3-Day Smart Driving Challenge in Samarkand, Powered by Greater Than
INDP

PR Newswire

a year ago

Getting smarter: FIA Launches 3-Day Smart Driving Challenge in Samarkand, Powered by Greater Than

3 Major Product Releases at 3Shape Discover Event
INDP

PR Newswire

a year ago

3 Major Product Releases at 3Shape Discover Event

Fiber Optic Sensors Global Market Forecast & Analysis 2023-2033: Global Fiber Optic Sensors Market to Reach $605.4 Million by 2032 with a CAGR of 6.2%
INDP

GlobeNewswire

a year ago

Fiber Optic Sensors Global Market Forecast & Analysis 2023-2033: Global Fiber Optic Sensors Market to Reach $605.4 Million by 2032 with a CAGR of 6.2%

Exploring SEHK Growth Companies With High Insider Ownership: BYD Leads The Way
INDP

Simply Wall St.

a year ago

Exploring SEHK Growth Companies With High Insider Ownership: BYD Leads The Way

INDP

Business Wire

a year ago

Net Asset Value(s)

Irish, Czechs hold EU vote after Dutch far-right gains
INDP

AFP

a year ago

Irish, Czechs hold EU vote after Dutch far-right gains

Trade the Nvidia Stock Split? The Tried-and-True Method to Make the Best Profits on the Leading AI Stock
INDP

Motley Fool

a year ago

Trade the Nvidia Stock Split? The Tried-and-True Method to Make the Best Profits on the Leading AI Stock

GPRC5D Targeting Drugs Market Opportunity and Clinical Trials Insight 2024: Insight on 15+ Drugs in Clinical Trials
INDP

GlobeNewswire

a year ago

GPRC5D Targeting Drugs Market Opportunity and Clinical Trials Insight 2024: Insight on 15+ Drugs in Clinical Trials

Indaptus Therapeutics to Present New Positive Data on Decoy20 at Next-Gen Immuno-Oncology Conference
INDP

GlobeNewswire

a year ago

Indaptus Therapeutics to Present New Positive Data on Decoy20 at Next-Gen Immuno-Oncology Conference

Indaptus Therapeutics Announces New Positive Data from Ongoing Phase 1 Trial of Decoy20
INDP

GlobeNewswire

a year ago

Indaptus Therapeutics Announces New Positive Data from Ongoing Phase 1 Trial of Decoy20

Indaptus Therapeutics to Present at the Jefferies Global Healthcare Conference
INDP

GlobeNewswire

a year ago

Indaptus Therapeutics to Present at the Jefferies Global Healthcare Conference

Indaptus Therapeutics to Present New Cohort Data Confirming Original “Pulse-Prime” Hypothesis Via Phase 1 Clinical Trial of Decoy20 at the American Society of Clinical Oncology Annual Meeting
INDP

GlobeNewswire

a year ago

Indaptus Therapeutics to Present New Cohort Data Confirming Original “Pulse-Prime” Hypothesis Via Phase 1 Clinical Trial of Decoy20 at the American Society of Clinical Oncology Annual Meeting

Indaptus Therapeutics Announces Completion of First Patient to Receive Multiple Doses of Decoy20, the Company’s Broad-Based, “Pulse-Prime” Immuno-Oncology Therapy for Advanced Solid Tumors
INDP

GlobeNewswire

a year ago

Indaptus Therapeutics Announces Completion of First Patient to Receive Multiple Doses of Decoy20, the Company’s Broad-Based, “Pulse-Prime” Immuno-Oncology Therapy for Advanced Solid Tumors

Indaptus Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
INDP

GlobeNewswire

a year ago

Indaptus Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

Indaptus Therapeutics Presents Positive Mechanism of Action Data at the American Association for Cancer Research Annual Meeting
INDP

GlobeNewswire

a year ago

Indaptus Therapeutics Presents Positive Mechanism of Action Data at the American Association for Cancer Research Annual Meeting

Indaptus Therapeutics to Present at the MedInvest Biotech and Pharma Investor Conference
INDP

GlobeNewswire

a year ago

Indaptus Therapeutics to Present at the MedInvest Biotech and Pharma Investor Conference

Indaptus Therapeutics Previews Positive Mechanism of Action Data to be Presented at the American Association for Cancer Research Annual Meeting
INDP

GlobeNewswire

a year ago

Indaptus Therapeutics Previews Positive Mechanism of Action Data to be Presented at the American Association for Cancer Research Annual Meeting

Indaptus Therapeutics to Participate in Tribe Public Webinar On Wednesday, March 20, 2024
INDP

GlobeNewswire

a year ago

Indaptus Therapeutics to Participate in Tribe Public Webinar On Wednesday, March 20, 2024

Indaptus Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
INDP

GlobeNewswire

a year ago

Indaptus Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update

Indaptus Therapeutics Announces Positive Results from Second Cohort of Phase 1 Trial; Company Initiates Multi-Dose Cohort
INDP

GlobeNewswire

a year ago

Indaptus Therapeutics Announces Positive Results from Second Cohort of Phase 1 Trial; Company Initiates Multi-Dose Cohort

Indaptus Therapeutics to Present at the 2024 BIO CEO & Investor Conference
INDP

GlobeNewswire

a year ago

Indaptus Therapeutics to Present at the 2024 BIO CEO & Investor Conference

Indaptus Therapeutics Expands Digital Presence with Launch of Social Media Channels
INDP

GlobeNewswire

a year ago

Indaptus Therapeutics Expands Digital Presence with Launch of Social Media Channels

Advanced Emissions Solutions Completes Rebrand as Arq and Will Ring NASDAQ Opening Bell on February 1, 2024
INDP

GlobeNewswire

a year ago

Advanced Emissions Solutions Completes Rebrand as Arq and Will Ring NASDAQ Opening Bell on February 1, 2024

Rhinebeck Bancorp, Inc. Reports Results for the Quarter and Year Ended December 31, 2023
INDP

ACCESSWIRE

a year ago

Rhinebeck Bancorp, Inc. Reports Results for the Quarter and Year Ended December 31, 2023

Advanced Emissions Solutions Signs Contract for Construction of Granular Activated Carbon Expansion at Red River Plant with Wieland
INDP

GlobeNewswire

a year ago

Advanced Emissions Solutions Signs Contract for Construction of Granular Activated Carbon Expansion at Red River Plant with Wieland

Yunhong Green CTI Announces Formation of New China Based Subsidiary, Yunhong Technology Industry (Hubei) Co., Ltd
INDP

ACCESSWIRE

a year ago

Yunhong Green CTI Announces Formation of New China Based Subsidiary, Yunhong Technology Industry (Hubei) Co., Ltd

INDP

GlobeNewswire

a year ago

Abpro Announces Filing of Registration Statement on Form S-4 in Connection with Business Combination Agreement with Atlantic Coastal Acquisition Corp. II

INDP

Business Wire

a year ago

Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Evaluating the Safety of Renuvion® Following Liposuction in Multiple Areas of the Body

Home Federal Bancorp, Inc. of Louisiana Declares Quarterly Cash Dividend
INDP

GlobeNewswire

a year ago

Home Federal Bancorp, Inc. of Louisiana Declares Quarterly Cash Dividend

Phoenix Issues Preliminary Guidance Following the Purchase of Proterra's Transit Business
INDP

ACCESSWIRE

a year ago

Phoenix Issues Preliminary Guidance Following the Purchase of Proterra's Transit Business

Golden Matrix Reports Fiscal 2023 Financial Results With Record Revenues of $44.2 Million
INDP

NewMediaWire

a year ago

Golden Matrix Reports Fiscal 2023 Financial Results With Record Revenues of $44.2 Million

Sidoti Events, LLC's Virtual January Micro-Cap Conference
INDP

ACCESSWIRE

a year ago

Sidoti Events, LLC's Virtual January Micro-Cap Conference

ClearPoint Neuro Announces FDA Clearance for SmartFrame OR™ Stereotactic System
INDP

GlobeNewswire

a year ago

ClearPoint Neuro Announces FDA Clearance for SmartFrame OR™ Stereotactic System

Advanced Emissions Solutions to Attend the Sidoti Micro-Cap Conference on January 17th and 18th
INDP

GlobeNewswire

a year ago

Advanced Emissions Solutions to Attend the Sidoti Micro-Cap Conference on January 17th and 18th

INDP

Newsfile

a year ago

Snow Lake Lithium CEO Update to Shareholders

Q3 Rundown: Molson Coors (NYSE:TAP) Vs Other Beverages and Alcohol Stocks
INDP

StockStory

a year ago

Q3 Rundown: Molson Coors (NYSE:TAP) Vs Other Beverages and Alcohol Stocks

Comstock Metals Receives Air Quality Permit from the State of Nevada
INDP

GlobeNewswire

a year ago

Comstock Metals Receives Air Quality Permit from the State of Nevada

INDP

Business Wire

a year ago

Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2023 Revenue Results

Elevation Oncology Announces Program Updates and Upcoming 2024 Milestones
INDP

PR Newswire

a year ago

Elevation Oncology Announces Program Updates and Upcoming 2024 Milestones

Catch the Future in Action: LeddarTech Unveils Its Award-Winning LeddarVision ADAS Products and Technology at CES Las Vegas 2024
INDP

CNW Group

a year ago

Catch the Future in Action: LeddarTech Unveils Its Award-Winning LeddarVision ADAS Products and Technology at CES Las Vegas 2024

European Patent Office Approves Key Patent for Indaptus Therapeutics’ Platform Technology
INDP

GlobeNewswire

a year ago

European Patent Office Approves Key Patent for Indaptus Therapeutics’ Platform Technology

Assertio Holdings, Inc. Announces Leadership Transition
INDP

GlobeNewswire

a year ago

Assertio Holdings, Inc. Announces Leadership Transition

Comstock (LODE) Executes First Commercial Biorefinery Deal
INDP

Zacks

a year ago

Comstock (LODE) Executes First Commercial Biorefinery Deal

5 Top Energy Growth Stocks That You Need to Buy for 2024
INDP

Zacks

a year ago

5 Top Energy Growth Stocks That You Need to Buy for 2024

Vital Energy (VTLE) in $55M Deal to Enhance Permian Presence
INDP

Zacks

a year ago

Vital Energy (VTLE) in $55M Deal to Enhance Permian Presence

Snail., Inc Unveils Everlasting Winter Wonderland Mod For ARK: Survival Ascended
INDP

GlobeNewswire

a year ago

Snail., Inc Unveils Everlasting Winter Wonderland Mod For ARK: Survival Ascended

Scilex Holding Company Announces that According to Prescription Data from Symphony Health, ZTlido® is the Most Prescribed Non-Opioid Branded Pain Treatment By Pain Specialists
INDP

GlobeNewswire

a year ago

Scilex Holding Company Announces that According to Prescription Data from Symphony Health, ZTlido® is the Most Prescribed Non-Opioid Branded Pain Treatment By Pain Specialists

Snow Lake Expands Its Lithium Portfolio with Mineral Claims Next to the Tanco Mine
INDP

Newsfile

a year ago

Snow Lake Expands Its Lithium Portfolio with Mineral Claims Next to the Tanco Mine

3 Growth Stocks That Can Double in 2024
INDP

InvestorPlace

a year ago

3 Growth Stocks That Can Double in 2024

Cara Therapeutics Announces Outcome from Dose-Finding Part A of KIND 1 Study Evaluating Oral Difelikefalin for Moderate-to-Severe Pruritus in Patients with Atopic Dermatitis
INDP

GlobeNewswire

a year ago

Cara Therapeutics Announces Outcome from Dose-Finding Part A of KIND 1 Study Evaluating Oral Difelikefalin for Moderate-to-Severe Pruritus in Patients with Atopic Dermatitis

Genasys Independent Director Acquires 13% More Stock
INDP

Simply Wall St.

a year ago

Genasys Independent Director Acquires 13% More Stock

INDP

InvestorPlace

a year ago

AMC Stock: This Dog With Fleas Just Won’t Die. Should You Buy? NO.

17 Education & Technology Group Inc. Announces Plan to Implement ADS Ratio Change
INDP

GlobeNewswire

a year ago

17 Education & Technology Group Inc. Announces Plan to Implement ADS Ratio Change

Penny Stock Jackpots: 3 High-Stakes Picks With 10-Bagger Potential
INDP

InvestorPlace

a year ago

Penny Stock Jackpots: 3 High-Stakes Picks With 10-Bagger Potential

Hycroft Regains Compliance with Nasdaq Listing Requirements
INDP

PR Newswire

a year ago

Hycroft Regains Compliance with Nasdaq Listing Requirements

Iterum Therapeutics Regains Compliance with Nasdaq Bid Price Rule
INDP

GlobeNewswire

a year ago

Iterum Therapeutics Regains Compliance with Nasdaq Bid Price Rule

Is It Too Late To Consider Buying DarioHealth Corp. (NASDAQ:DRIO)?
INDP

Simply Wall St.

a year ago

Is It Too Late To Consider Buying DarioHealth Corp. (NASDAQ:DRIO)?

7 Sorry Meme Stocks to Sell in December
INDP

InvestorPlace

a year ago

7 Sorry Meme Stocks to Sell in December

INDP

Business Wire

a year ago

Vince Holding Corp. Announces Participation in the Sidoti Small Cap Conference

Share on Social Networks: